The iPro™ system provides data used by healthcare professionals to personalize therapy adjustments that may reduce glucose variability and improve A1C.1–5
Placed on the patient’s abdomen, the iPro™2 recorder and sensor are worn for up to six days.WATCH VIDEO
What does the iPro™2 Professional CGM device do?
If you’re interested in learning more about iPro™2 Professional CGM, submit the form below and a Medtronic Diabetes representative will contact you to schedule a product demo and answer any questions you may have.
Watch these videos for the complete iPro™2 system training:
Mohan V, Jain S, Kesavadev J, et al. Use of retrospective continuous glucose monitoring for optimizing management of type 2 diabetes in India. Journal of The Association of Physicians of India, 2016: 64:16–21.
Leinung M, Nardacci E, Patel N, Bettadahalli S, Paika K, Thompson S. Benefits of short-term professional continuous glucose monitoring in clinical practice. Diabetes Technology & Therapeutics. 2013;15(9):744-747.
Allen N, Fain J, Braun B, Chipkin S. Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial. Diabetes Research and Clinical Practice. 2008;80(3):371-379.
Kesavadev J, Vigersky R, Shin J, et al. Assessing the therapeutic utility of professional continuous glucose monitoring in type 2 diabetes across various therapies: A retrospective evaluation. Advances in Therapy. 2017;34(8):1918-1927.
Kim S, Kim H, Kim T, et al. Effectiveness of 3-day continuous glucose monitoring for improving glucose control in type 2 diabetic patients in clinical practice. Diabetes & Metabolism Journal. 2014;38(6):449.